ASSOCIATION OF SGLT2 INHIBITORS WITH STROKE IN PATIENTS WITH TYPE 2 DIABETES: A SYSTEMATIC REVIEW AND META-ANALYSIS

被引：0
|
作者：
Mi, D. [1 ]
Pan, P. [1 ]
Chen, S. [1 ]
Chen, S. [1 ]
Peng, F. [1 ]
机构：
[1] Capital Med Univ, Beijing Tiantan Hosp, Beijing, Peoples R China
来源：
INTERNATIONAL JOURNAL OF STROKE | 2024年 / 19卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
SO067 / #
引用
收藏
页码：88 / 88
页数：1
相关论文
共 50 条
  • [1] SGLT2 inhibitors and risk of stroke in patients with type 2 diabetes: A systematic review and meta-analysis
    Guo, Man
    Ding, Jingya
    Li, Jingsong
    Wang, Jiying
    Zhang, Ting
    Liu, Cuiping
    Huang, Wei
    Long, Yang
    Gao, Chenlin
    Xu, Yong
    DIABETES OBESITY & METABOLISM, 2018, 20 (08): : 1977 - 1982
  • [2] SGLT2 Inhibitors and Stroke Risk in Patients with Type 2 Diabetes-A Systematic Review and Meta-analysis
    Guo, Man
    Xu, Yong
    DIABETES, 2018, 67
  • [3] Effects of SGLT2 inhibitors on stroke and its subtypes in patients with type 2 diabetes: a systematic review and meta-analysis
    Tsai, Wen-Hsuan
    Chuang, Shih-Ming
    Liu, Sung-Chen
    Lee, Chun-Chuan
    Chien, Ming-Nan
    Leung, Ching-Hsiang
    Liu, Shu-Jung
    Shih, Hong-Mou
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [4] Effects of SGLT2 inhibitors on stroke and its subtypes in patients with type 2 diabetes: a systematic review and meta-analysis
    Wen-Hsuan Tsai
    Shih-Ming Chuang
    Sung-Chen Liu
    Chun-Chuan Lee
    Ming-Nan Chien
    Ching-Hsiang Leung
    Shu-Jung Liu
    Hong-Mou Shih
    Scientific Reports, 11
  • [5] SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis
    Neuen, Brendan L.
    Young, Tamara
    Heerspink, Hiddo J. L.
    Neal, Bruce
    Perkovic, Vlado
    Billot, Laurent
    Mahaffey, Kenneth W.
    Charytan, David M.
    Wheeler, David C.
    Arnott, Clare
    Bornpoint, Severine
    Levin, Adeera
    Jardine, Meg J.
    LANCET DIABETES & ENDOCRINOLOGY, 2019, 7 (11): : 845 - 854
  • [6] Systematic review and meta-analysis of the efficacy and safety of SGLT2 inhibitors in patients with type 2 diabetes mellitus
    Tsapas, A.
    Vassilakou, D.
    Athanasiadou, E.
    Karagiannis, T.
    Matthews, D. R.
    DIABETOLOGIA, 2012, 55 : S107 - S107
  • [7] Dose-ranging effects of SGLT2 inhibitors in patients with type 2 diabetes: a systematic review and meta-analysis
    Pinto, Lana C.
    Rados, Dimitris, V
    Remonti, Luciana R.
    Viana, Marina V.
    Leitao, Cristiane B.
    Gross, Jorge L.
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2022, 66 (01): : 68 - 76
  • [8] Dose-ranging effects of SGLT2 inhibitors in patients with type 2 diabetes: a systematic review and meta-analysis
    Pinto, L. C.
    Rados, D. R.
    Retnonti, L. R.
    Viana, M. V.
    Leitao, C. B.
    Gross, J. L.
    DIABETOLOGIA, 2018, 61 : S313 - S313
  • [9] Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes A Meta-analysis
    McGuire, Darren K.
    Shih, Weichung J.
    Cosentino, Francesco
    Charbonnel, Bernard
    Cherney, David Z. I.
    Dagogo-Jack, Samuel
    Pratley, Richard
    Greenberg, Michelle
    Wang, Shuai
    Huyck, Susan
    Gantz, Ira
    Terra, Steven G.
    Masiukiewicz, Urszula
    Cannon, Christopher P.
    JAMA CARDIOLOGY, 2021, 6 (02) : 148 - 158
  • [10] Effect of SGLT2 Inhibitors on Risk of Stroke in Diabetes: A Meta-Analysis
    Zhang, Chunhui
    Zhang, Xian
    Wang, Peng
    Zhu, Qinghua
    Mei, Yongxia
    Zhang, Zhenxiang
    Xu, Hui
    CEREBROVASCULAR DISEASES, 2022, 51 (05) : 585 - 593
12345